Cytarabine hydrochloride is an antipyrimidine antimetabolite, which belongs to the specific drug acting on the S cell cycle, which can inhibit DNA polymerase, interfere with DNA synthesis, and have anticancer effects. It has an inhibitory effect on some DNA viruses, especially chickenpox, herpes zoster and herpes simplex virus are the most sensitive to this product. It is a powerful immunosuppressant of humoral immunity and cellular immune system.
Cytarabine hydrochloride is an important anti-leukemia drug, which can interfere with the synthesis of DNA by DNA in vivo, thereby inhibiting the reproduction of white blood cells and achieving anti-tumor pharmacological effects. Its toxicity is low, and it has obvious efficacy for some acute myeloid leukemia, acute monocytic leukemia, and erythrocyte leukemia that are difficult to alleviate.
Cytarabine hydrochloride is a pyrimidine antimetabolite, which is mainly used for the treatment of acute myelogenous leukemia and gastrointestinal tumors, and is the most common drug for the treatment of leukemia.
Specifications of Cytarabine Hydrochloride CAS 69-74-9
Product Name | Cytarabine hydrochloride |
Synonyms | 1-beta-D-Arabinofuranosylcytosine hydrochloride |
CAS No. | 69-74-9 |
EINECS | 200-713-9 |
MF | C9H14ClN3O5 |
MW | 279.68 |
Appearance | Powder |
Melting Point | 189~195°C |
Purity | ≥99.0% |
There are many active pharmaceutical ingredient manufacturers, but we are one of the best choices for you.
No comments:
Post a Comment